Pathstone Holdings
CRNX icon

Pathstone Holdings’s Crinetics Pharmaceuticals CRNX Stock Holding History

Pathstone Holdings’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$727K Sell
25,273
-3,042
-11% -$87.5K ﹤0.01% 1545
2025
Q1 		$950K Buy
28,315
+7,887
+39% +$265K ﹤0.01% 1412
2024
Q4 		$1.04M Buy
+20,428
New +$1.04M ﹤0.01% 1348